AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

0.000p
   
  • Closing Price Chg:
    -20.00p
  • 52 Week High: 0.000p
  • 52 Week Low: 0.000p
  • Currency: UK Pounds
  • Shares Issued: 1,550.68m
  • Volume: 0
  • RiskGrade: 123

Other News

FTSE close: Next up; Barclays & UU down 22-Jun-2011 This Is Money
Midas: At last, Dogs are setting the pace 14-May-2011 This Is Money
How to enjoy the dividend revival 14-May-2011 This Is Money
FTSE in-depth: Greene King the toast of analysts 13-May-2011 This Is Money
FTSE preview: Rebound led by defensive stocks 13-May-2011 This Is Money
FTSE in-depth: Qatari bid talk fires up Centrica 12-May-2011 This Is Money
FTSE preview: Shares to follow US lower 12-May-2011 This Is Money
Landlord stock jumps on potential Lloyds deal 04-May-2011 This Is Money
FTSE in-depth: Traders get post wedding blues 04-May-2011 This Is Money
FTSE close: Miners suffer, Thorntons down 03-May-2011 This Is Money
FTSE close: Unilever, Whitbread down; WPP up 28-Apr-2011 This Is Money
FTSE 100 preview: US boost for shares 28-Apr-2011 This Is Money
FTSE preview: Sluggish start after holiday 26-Apr-2011 This Is Money
City diary: Week ahead in the markets 21-Apr-2011 This Is Money
Centamin Egypt shares fall by 8.5% 20-Apr-2011 This Is Money
AstraZeneca to sell £1.3bn dental unit 17-Apr-2011 This Is Money
Fund managers make £3.5bn but your pro... 29-Mar-2011 This Is Money
AstraZeneca shares rise on tax bill boost 28-Mar-2011 This Is Money
FTSE close: Banks lead gains, AZ relief 28-Mar-2011 This Is Money
FTSE preview: Libya dampens shares, oil soars 24-Feb-2011 This Is Money

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 11,876.00p
Closing Price Change -20.00p
% Change 0.00 %
52 Week High 0.000p
52 Week Low 0.000p
Volume 0
Shares Issued 1,550.68m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 4
Sell 0
Strong Sell 0
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page